By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Synergy Pharma Provides Update On Ongoing FDA Review Of Plecanatide CIC NDA And IBS-C Clinical Development Program 7/15/2016 10:18:13 AM
Synergy Pharma Presents New In Vitro Data Showing The pH-Dependent Activity Of Plecanatide Replicates That Of Naturally Occurring GI Peptide Uroguanylin 5/25/2016 11:03:54 AM
Synergy Pharma Presents New In Vitro Data Showing The pH-Dependent Activity Of Plecanatide Replicates That Of Naturally Occurring GI Peptide Uroguanylin 5/25/2016 10:33:12 AM
Synergy Pharma Presents Additional Phase 3 Plecanatide Data In Chronic Idiopathic Constipation At Digestive Disease Week 5/23/2016 10:10:52 AM
Synergy Pharma To Present New Plecanatide Data At Digestive Disease Week 2016 5/16/2016 10:32:27 AM
Synergy Pharma Reports First Quarter 2016 Financial Results And Business Update 5/11/2016 10:27:00 AM
Synergy Pharma Announces Closing Of $89.8 Million Registered Direct Offering Of Common Stock 5/10/2016 12:50:53 PM
Synergy Pharma Announces $89.8 Million Registered Direct Offering Of Common Stock 5/5/2016 10:50:43 AM
Synergy Pharma Announces Resignation Of Chief Financial Officer 4/28/2016 10:28:40 AM
Synergy Pharma To Present At The Deutsche Bank (DB) Health Care Conference 4/26/2016 11:43:06 AM
12345678910...
//-->